Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to zap shoulder pain without drugs

NCT ID NCT07550543

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding pulsed electromagnetic field (PEMF) therapy to standard physical therapy and spa treatments can reduce pain and improve shoulder function in people with chronic shoulder tendinopathy. Sixty adults aged 18 to 70 with shoulder pain lasting over 3 months will receive either standard care or standard care plus daily PEMF sessions for two weeks. Researchers will measure pain, function, and quality of life right after treatment and again four weeks later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulsed electromagnetic field therapy via a device called Super Inductive System
What this could lead to
If it works, this could offer a non-invasive, drug-free way to ease shoulder pain and improve function for people with chronic tendinopathy.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The treatment is added to standard rehab, making it hard to know how much benefit comes from the device alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged between 18 and 70 years. * Patients with chronic shoulder pain lasting more than 3 months, of non-traumatic origin, persistent despite prior conservative treatment. * Clinical diagnosis of shoulder tendinopathy and/or subacromial pain syndrome based on medical history and physical examination. * Presence of shoulder pain and functional limitation confirmed by clinical assessment and baseline functional evaluation (SPADI). * Ability to comply with the treatment protocol and attend scheduled follow-up assessments. * Provision of written informed consent prior to participation. Exclusion Criteria: * Full-thickness rotator cuff tears with surgical indication. * Recent major shoulder trauma (within the last 6 months). * Active systemic inflammatory or rheumatologic diseases. * Presence of metallic implants in the treatment area or implanted electronic devices (e.g., pacemaker). * Neurological disorders affecting the upper limb. * Contraindications to balneotherapy (e.g., severe cardiovascular disease, renal failure, severe dermatological conditions). * Decompensated chronic diseases at the time of enrollment (cardiovascular, hepatic, renal, respiratory, or neurological). * Skin lesions at the site of treatment application. * Pregnancy or breastfeeding. * Active neoplastic disease. * Decompensated psychiatric disorders. * History of hypersensitivity to natural therapeutic factors used in balneotherapy. * Refusal to participate or inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shoulder tendinopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Balneal and Rehabilitation Sanatorium of Techirghiol

    RECRUITING

    Constanța, Techirghiol, 906100, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.